Cellbricks Therapeutics is a series b startup. 1 investor tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
Cellbricks Therapeutics focuses on developing 3D-printed human tissues for pharmaceutical research and regenerative medicine.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky